8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat

Bioeffects Seen

Authors not listed · 1981

Share:

Melatonin reduced cancer rates by 75% in this study, but EMF exposure suppresses this protective hormone daily.

Plain English Summary

Summary written for general audiences

Researchers gave rats a cancer-causing chemical and found that melatonin (a hormone made by the pineal gland) dramatically reduced mammary tumor rates from 79% to just 20%. When they surgically removed the pineal gland, tumor rates jumped to 88%, showing this gland's protective role against breast cancer.

Why This Matters

This foundational 1981 study reveals something crucial that connects directly to EMF exposure concerns today. The pineal gland produces melatonin, our body's master antioxidant and cancer-fighting hormone. But here's what matters for your daily life: EMF exposure suppresses melatonin production by disrupting the pineal gland's function. When you use devices that emit EMF, you're essentially creating the same biological condition these researchers created surgically - reduced melatonin protection against cancer.

The science demonstrates that melatonin isn't just about sleep. This study shows it can reduce cancer rates by nearly 75%. Yet every night you sleep with your phone nearby, every day you're surrounded by WiFi and wireless devices, you're suppressing this critical protective hormone. The reality is that EMF exposure may be undermining one of your body's most powerful natural defenses against cancer development.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (1981). Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Show BibTeX
@article{melatonin_inhibition_and_pinealectomy_enhancement_of_712_dimethylbenzaanthracene_induced_mammary_tumors_in_the_rat_ce1628,
  author = {Unknown},
  title = {Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat},
  year = {1981},
  
  
}
PubMed: 6796259

Quick Questions About This Study

Yes, this study found melatonin treatment reduced mammary tumor incidence from 79% in control rats to just 20% in treated rats when given daily for 90 days alongside a cancer-causing chemical.
Rats with surgically removed pineal glands had 88% tumor rates compared to 22% in control animals, demonstrating the gland's critical role in cancer protection through melatonin production.
No, melatonin only partially reversed pinealectomy effects, reducing tumor rates from 87% to 63%. However, intact pineal glands with melatonin treatment achieved much lower 27% tumor rates.
The research suggests melatonin works by suppressing plasma prolactin levels. Melatonin-treated rats had significantly lower prolactin concentrations (27 ng/ml) compared to controls (65 ng/ml), which may inhibit tumor development.
Researchers used 2.5 mg/kg of melatonin given daily in the afternoon for 90 days, starting the same day as the cancer-causing chemical treatment in Sprague-Dawley rats.